The Board of Directors of Genovis AB (publ) has decided to reschedule the Annual General Meeting to May 5, 2015, as well as to raise capital through a fully underwritten rights issue, subject to approval by the AGM on May 5, 2015. The rights issue comprises a maximum of 14,563,768 shares and the subscription price will be SEK 1 per share. At full subscription the rights issue will raise approximately SEK 14.5 million before issue expenses for Genovis. Genovis is experiencing strong confidence in the company's products, with growing demand in both Europe and the US. The purpose of the rights issue is to be able to maintain the pace of sales and allow for a more powerful expansion in these two markets. Subscription and underwriting commitments have been obtained, corresponding to 100 percent of the total proceeds of the rights issue. The Board proposes that the Annual General Meeting approve the Board’s proposal to conduct a preferential rights issue of shares in which three (3) existing shares entitle the holder to subscription for two (2) new shares at a subscription price of SEK 1/ share. As a result of this resolution share capital could increase by a maximum of SEK 3,640,942 through the issuance of up to 14,563,768 shares. In the event that all shares are not subscribed for on the basis of subscription rights, allocation of shares shall be made within the scope of the maximum amount of the share issue, at which the Board shall allocate the shares firstly to those who have subscribed for shares on basis of subscription rights, pro rata in relation to their subscription on the basis of subscription rights, secondly to those who have declared their interest to subscribe for shares without subscription rights, pro rata in relation to their declared interest and last to guarantors in proportion to their guarantee undertakings. Following the completed rights issue, share capital will amount to a maximum of SEK 9,102,355 and the number of shares to a maximum of 36,409,420. The company will raise about SEK 14.5 million before issue expenses, which are expected to be about SEK 500,000. The issue will have a dilutive effect of 40 percent on the holdings of those who do not subscribe to the rights issue for their full stake. Timetable for rights issue May 11, 2015: Last trading day for the Genovis share including subscription rights for the new issue. May 13, 2015: Record date for participation in the new issue; shareholders registered in Genovis’ share register on this day receive subscription rights for participation in the new issue. May 18 – June 1, 2015: Subscription period, subscription with preferential rights through cash payment during the subscription period. Shareholders may report their intention to subscribe throughout the subscription period. Resolutions on the issuance of shares are subject to and conditional upon the Meeting also resolving on reduction of share capital and amendment of the Articles of Association; both of these resolutions are proposed to the same General Meeting. A Memorandum will be sent to the company’s shareholders that will provide the full terms, instructions and more information on the rights issue and Genovis. The Memorandum will be available on the company’s website www.genovis.com beginning on May 13, 2015. The notice is published in a separate press release and will be published in Post- och Inrikes tidningar and on the company's website within the next few days. For more information, please contact: Sarah Fredriksson, CEO, Genovis AB Tel: 0046 (0)46 -101235 sarah.fredriksson@genovis.com ABOUT GENOVIS Genovis’ business concept is to develop, produce and market innovative technologies that facilitate and enable development of new treatment methods and diagnostics for customers in the medical device and pharmaceutical industries. The Group consists of Genovis AB and the subsidiary GeccoDots AB. Genovis develops and sells unique enzymes in innovative product formats that facilitate development and quality control of and biological drugs. GeccoDots uses nanotechnology to produce a new type of contrast agent that is used in medical imaging. Genovis shares are listed on NASDAQ Stockholm First North, and Consensus is Certified Adviser for the Company, t: 46 (0)31-745 50 00
The Board of Directors of Genovis AB (publ) resolves on
Top 10 Most Recent News Articles
NVE Revenue Pull-Forward Raises Hard Investor Questions
A Quarter Can Look Great Until It Doesn’t NVE investors got a nasty lesson in revenue timing, the sort that makes even old hands check the fine print twice. On July 22, 2026, the company reported sequential revenue growth of 43% and net-income growth of 23%. The next trading day, shares vaulted $47.53, or 54%. Then came October, and the floor gave way: NVE reported that...
Continue Reading
Holland America Puts 2028 Alaska Demand on Display
Alaska’s interior is where a cruise brochure either earns its keep or gets exposed. Holland America Line is opening bookings for 2028 Alaska Cruisetours nearly two years ahead, tying a coast-and-land product to the reimagined Oosterdam’s Alaska debut. That is not merely another itinerary release. It is a fairly deliberate attempt to sell a bigger, longer and...
Continue Reading
NYSE Message Record Puts Market Plumbing Into Focus
A trillion messages is not a cute little exchange statistic; it is the sort of number that tells you whether the market’s pipes can keep working when everybody starts shouting at once. NYSE says it handled a record 1.166 trillion messages in one day on November 5, roughly 4% above the prior high set amid April 2025 volatility. Better yet, according to the exchange,...
Continue Reading
Yiwu Squishies Turn Viral Demand Into Factory Backlogs Worldwide
A pizza-shaped stress toy booking more than one million units is the sort of detail that makes a jaded market watcher sit up before rolling his eyes at the word “viral.” Yiwu’s squishy-toy surge appears to have moved beyond a few social-media impulses and into actual factory scheduling, repeat purchase orders and supermarket procurement. That is meaningful. It is...
Continue Reading
Five Films Put Modern Infrastructure Under a Lens
Most infrastructure only earns a thought when it breaks, and that is precisely the nerve these films are trying to touch. Nicely Done Productions has released the final five installments of its ten-part Threads of Connectivity documentary series, hosted on National Geographic's global digital platform. The subjects are illycaffè, Cargill, Honeywell Aerospace, Western...
Continue Reading
Africa’s Digital Leap Still Has a 64% Usage Problem
A continent can be blanketed in signal and still feel digitally stranded. That is the stubborn fact sitting inside the GSMA Digital Africa Index 2026: mobile broadband reaches 92% of Africa’s population, while only 28% use mobile internet on their own devices. The 64% usage gap is not a rounding error or a tidy policy footnote. It is the whole unfinished job. From an...
Continue Reading
MFB Bancorp Offering Puts Chicago Bank Conversion First
A small Chicago thrift is asking investors to fund a corporate makeover, and the fine print matters more than the $10 sticker price. MFB Bancorp has commenced an offering tied to the planned conversion of Mutual Federal Bancorp, MHC from a mutual holding company structure into a stock holding company. This is not some high-growth bank story with a shiny new branch map. It...
Continue Reading
StoneX Selloff Puts Earnings Quality Under a Harsh Lens
A revenue beat can turn downright useless when the profit line springs a leak. StoneX Group delivered operating revenue above expectations and record full-year results, then watched investors hammer the stock after fiscal fourth-quarter diluted earnings per share landed at $0.66. That was $0.15 below the roughly $0.81 consensus cited in the notice, and other estimates...
Continue Reading
IDEMIA Lands Sweden's Critical 5G Connectivity Job
A hospital monitor going dark because a device was misprovisioned is not the kind of connectivity hiccup anybody gets to shrug off. That is why IDEMIA Secure Transactions winning the Region Västra Götaland assignment deserves more attention than the usual telecom plumbing announcement. The region is building what it calls Sweden's largest private 5G network, and the job...
Continue Reading
Securitize Tests the IPO Clock With Anthropic Tokens
Anthropic did not even get a full trading day to itself before the tokenization crowd arrived. Securitize says Anthropic stock became available through Securitize Stocks on Solana on the company’s first day as a public company, a loud little signal that the old IPO playbook is being prodded from the edges. For investors, this is not merely another crypto-flavored...
Continue ReadingTop 5 Most Recently Viewed Articles
Exploring the Growth of the Global Gifts Retailing Market
The Gifts Retailing Market is Evolving Rapidly The global gifts retailing industry is projected to experience substantial growth, with estimates indicating an increase of USD 11.01 billion from 2024 to 2028. Several influential factors are driving this trend, notably the rising demand for seasonal decorations and a stronger gifting culture. As consumers increasingly...
Continue Reading
Exploring the Risks Behind the Monumental Rise of Big Tech
Understanding the Current Landscape of Big Tech Investment In recent discussions about the tech industry, significant concerns have bubbled to the surface regarding the sustainability of current market valuations. Analysts have pointed out that the optimism surrounding the surge in equity prices may be fueled by unrealistic expectations. John Hussman notably remarked on...
Continue Reading
Senator Markwayne Mullin Makes Notable Stock Purchase in LPL
Senator Markwayne Mullin's Recent Stock Transactions Recent financial disclosures reveal that Senator Markwayne Mullin has made a significant investment in LPL Financial Holdings Inc (NASDAQ: LPLA). The purchase, valued between $233,016 and $670,000, was filed recently and adds to his active trading portfolio. This transaction indicates Mullin's ongoing interest in the...
Continue Reading
Pathward Financial: Sale of Insurance Business Extended
Pathward Financial, Inc. (NASDAQ: CASH), known as Meta Financial Group in the past, extended the closing of its commercial insurance premium finance business sale to October 22, from an initial deadline of October 1. Traders were quick to sniff out that this delay wasn’t just a minor hiccup—it pointed to deeper operational challenges. Delays and What They Mean for...
Continue Reading
Vallourec's Major Supply Order from ADNOC Signals Growth
Vallourec's Major Supply Agreement with ADNOC Vallourec, a global leader in premium seamless tubular solutions, has successfully secured a significant order from the Abu Dhabi National Oil Company (ADNOC). This order includes supplying over 30,000 tons of carbon steel tubulars and related accessories, prominently featuring VAM premium connections. This transaction forms...
Continue Reading